Tools
Tools
Alexandre, Leo, Tsilegeridis-Legeris, Theo and Lam, Stephen 
ORCID: https://orcid.org/0000-0003-1040-938X
(2022)
Clinical and endoscopic characteristics associated with post-endoscopy upper gastrointestinal cancers: A systematic review and meta-analysis.
Gastroenterology, 162 (4).
pp. 1123-1135.
ISSN 0016-5085
Preview |
PDF (Accepted_Manuscript)
- Accepted Version
Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (5MB) | Preview |
Abstract
Background & aims: Ten percent of patients with an upper gastrointestinal cancer will have received an esophagogastroduodenoscopy (EGD) within 3 years before diagnosis, termed post-endoscopy upper gastrointestinal cancers (PEUGIC). We aimed to determine the characteristics of PEUGIC, and compare these with detected cancers. Methods: We searched MEDLINE and Embase from inception for studies comparing the characteristics of PEUGIC and detected upper gastrointestinal cancers, and reported findings at the initial “cancer-negative” endoscopy. We synthesized results using random effects meta-analysis. This review is registered on PROSPERO, CRD42019125780. Results: A total of 2696 citations were screened and 25 studies were included, comprising 81,184 UGI cancers, of which 7926 were considered PEUGIC. For PEUGIC assessed within 6 to 36 months of a “cancer-negative” EGD, the mean interval was approximately 17 months. Patients with PEUGIC were less likely to present with dysphagia (odds ratio [OR] 0.37) and weight loss (OR 0.58) and were more likely to present with gastroesophageal reflux (OR 2.64) than detected cancers. PEUGICs were more common in women in Western populations (OR 1.30). PEUGICs were typically smaller at diagnosis and associated with less advanced disease staging compared with detected cancers (OR 2.87 for stage 1 vs 2–4). Most EGDs (>75%) were abnormal preceding diagnosis of PEUGIC. Conclusions: There is a substantial delay in the diagnosis of PEUGIC. They are less likely to present with alarm symptoms than detected cancers. PEUGICs are overall less advanced at diagnosis. Most patients with PEUGIC have abnormalities reported at the preceding “cancer-negative” EGD. The epidemiology of PEUGIC may inform preventive strategy.
| Item Type: | Article |
|---|---|
| Additional Information: | Funding Information: Stephen Lam, NIHR Clinical Lecturer, is funded by the National Institute for Health Research (NIHR) for this research project. The views expressed in this publication are those of the authors and not necessarily those of the NIHR, NHS, or the UK Department of Health and Social Care. |
| Uncontrolled Keywords: | missed lesions,peec,pegc,quality indicators,gastroenterology,hepatology,sdg 3 - good health and well-being ,/dk/atira/pure/subjectarea/asjc/2700/2715 |
| Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
| UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Gastroenterology and Gut Biology Faculty of Science > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Groups > Norwich Epidemiology Centre Faculty of Medicine and Health Sciences > Research Centres > Metabolic Health |
| Related URLs: | |
| Depositing User: | LivePure Connector |
| Date Deposited: | 04 Jan 2022 10:30 |
| Last Modified: | 06 Jun 2024 15:17 |
| URI: | https://ueaeprints.uea.ac.uk/id/eprint/82853 |
| DOI: | 10.1053/j.gastro.2021.12.270 |
Downloads
Downloads per month over past year
Actions (login required)
 |
View Item |